High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
G. Walldius, I. Jungner, I. Holme, A. Aastveit, W. Kolar, and E. Steiner. Lancet, (Dec 15, 2001)Recently, the Apolipoprotein-Related Mortality Risk Study published prospective data in 175,553 men and women and found that the total apo B level was a better predictor of future CAD risk than LDL cholesterol.<br /><br />Importantly, they also found that apo B was a better predictor of CAD risk in individuals with low LDL levels, supporting the idea that patients with low LDL cholesterol levels and increased quantities of small, dense atherogenic particles (VLDL, IDL, and LDL) are at risk for CAD. (scavalieri 2005-08-21 21:51:58).
Recently, the Apolipoprotein-Related Mortality Risk Study published prospective data in 175,553 men and women and found that the total apo B level was a better predictor of future CAD risk than LDL cholesterol.<br /><br />Importantly, they also found that apo B was a better predictor of CAD risk in individuals with low LDL levels, supporting the idea that patients with low LDL cholesterol levels and increased quantities of small, dense atherogenic particles (VLDL, IDL, and LDL) are at risk for CAD. (scavalieri 2005-08-21 21:51:58)
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 Walldius2001
%A Walldius, G.
%A Jungner, I.
%A Holme, I.
%A Aastveit, A. H.
%A Kolar, W.
%A Steiner, E.
%D 2001
%J Lancet
%K ApoB Lipids
%P 2026--2033
%T High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
%U http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=11755609&dopt=Abstract
%V 358
@article{Walldius2001,
added-at = {2009-05-17T10:12:22.000+0200},
author = {Walldius, G. and Jungner, I. and Holme, I. and Aastveit, A. H. and Kolar, W. and Steiner, E.},
biburl = {https://www.bibsonomy.org/bibtex/275b9c6593c5a5bfcdda10f234f57af48/freefattyacids},
day = 15,
description = {From Connotea},
interhash = {cbcfc8ead4f7f5e8d7d124950b9bb06a},
intrahash = {75b9c6593c5a5bfcdda10f234f57af48},
issn = {0140-6736},
issue = {9298},
journal = {Lancet},
keywords = {ApoB Lipids},
month = Dec,
note = {Recently, the Apolipoprotein-Related Mortality Risk Study published prospective data in 175,553 men and women and found that the total apo B level was a better predictor of future CAD risk than LDL cholesterol.<br /><br />Importantly, they also found that apo B was a better predictor of CAD risk in individuals with low LDL levels, supporting the idea that patients with low LDL cholesterol levels and increased quantities of small, dense atherogenic particles (VLDL, IDL, and LDL) are at risk for CAD. (scavalieri 2005-08-21 21:51:58)},
pages = {2026--2033},
timestamp = {2010-03-01T10:23:44.000+0100},
title = {High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.},
url = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=11755609&dopt=Abstract},
volume = 358,
year = 2001
}